Logo image
Endothelial biomarkers of thrombosis in critically ill patients with acquired coagulopathy: A prospective cohort study
Journal article   Peer reviewed

Endothelial biomarkers of thrombosis in critically ill patients with acquired coagulopathy: A prospective cohort study

Y. Harahsheh, H. Ludewick, W. Pavey and K.M. Ho
Biomarkers in Medicine, Vol.16(9), Art. 0576
2022
url
Link to Published Version *Subscription may be requiredView

Abstract

Background: It remains largely unknown whether endothelial biomarkers can be used to predict thromboembolism in critically ill patients with an acquired coagulopathy. Materials & methods: The ability of syndecan-1, P-selectin and microRNA expressions to predict thromboembolism were assessed in 40 critically ill coagulopathic patients. Results: The area under the receiver operating characteristic curves for syndecan-1, P-selectin and the four differentially expressed microRNAs – determined by real-time qPCR analysis – to predict thromboembolism (n = 10, 25%) were 0.71 (95% CI 0.52–0.89), 0.73 (95% CI 0.52–0.95) and >0.80, respectively. Syndecan-1 and P-selectin concentrations were also significantly correlated with one another (R = 0.41, p = 0.008). Conclusion: Endothelial function biomarkers, including endothelial microRNA expressions, were associated with subsequent thromboembolism in critically ill patients who had a deranged coagulation profile.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

70 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.196 Micro & Long Noncoding RNA
1.196.68 MicroRNA in Cancer
Web Of Science research areas
Medicine, Research & Experimental
ESI research areas
Molecular Biology & Genetics
Logo image